This is particularly evident in breast cancer, where uPA and PAI-1 represent potent prognostic factors, with a predictive value stronger than those of patient age, tumor size, estrogen, and progesterone receptors, HER-2/neu, or p53 expression [175,176]. The gene discussed is ERBB2; the disease is breast carcinoma.